Skip to main content

Zynteglo Side Effects

Generic name: betibeglogene autotemcel

Medically reviewed by Drugs.com. Last updated on Dec 28, 2023.

Note: This document contains side effect information about betibeglogene autotemcel. Some dosage forms listed on this page may not apply to the brand name Zynteglo.

Applies to betibeglogene autotemcel: intravenous suspension.

Serious side effects of Zynteglo

Along with its needed effects, betibeglogene autotemcel (the active ingredient contained in Zynteglo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking betibeglogene autotemcel:

More common

Less common

Other side effects of Zynteglo

Some side effects of betibeglogene autotemcel may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to betibeglogene autotemcel: intravenous suspension.

Cardiovascular

Common (1% to 10%): Hypertension, congestive heart failure, tachycardia[Ref]

-Increased heart rate on the day of treatment is likely.[Ref]

Dermatologic

Very common (10% or more): Alopecia (44%), rash (27%), pigmentation disorder (24%), pruritus (22%)[Ref]

-Rash includes acne, dermatitis acneiform, dermatitis atopic, macule, petechiae, rash, follicular rash, macular rash, maculo-papular rash, pruritic rash, pustular rash, and vesicular rash.

-Pigmentation disorder includes oral pigmentation, pigmentation disorder, skin hyperpigmentation, and skin hypopigmentation.[Ref]

Gastrointestinal

Very common (10% or more): Mucositis (95%), vomiting (49%), abdominal pain (39), diarrhea (27%), nausea (24%), constipation (24%)

Common (1% to 10%): Dyspepsia, gingival bleeding[Ref]

-Mucositis includes anal inflammation, mucosal inflammation, oral mucosal exfoliation, oral mucosal roughening, pharyngeal inflammation, and stomatitis.

-Abdominal pain includes abdominal pain, lower abdominal pain, abdominal discomfort, and upper abdominal pain.

-Abdominal pain on the day of treatment is likely.[Ref]

General

The most common adverse reactions with a frequency of 20% or more were mucositis, febrile neutropenia, vomiting, pyrexia (fever), alopecia (hair loss), epistaxis (nosebleed), abdominal pain, musculoskeletal pain, cough, headache, diarrhea, rash, constipation, nausea, decreased appetite, pigmentation disorder, and pruritus (itch).

The most common serious adverse reactions with a frequency of more than 3% were pyrexia (fever), thrombocytopenia, liver veno-occlusive disease, febrile neutropenia, neutropenia, and stomatitis.[Ref]

Hematologic

Very common (10% or more): Neutropenia (100%), thrombocytopenia (100%), leukopenia (100%), febrile neutropenia (51%), transfusion reaction (15%) , anemia (95%), lymphopenia (61%), decreased neutrophil count[Ref]

-Decreased neutrophil counts occurred in Granulocyte-colony stimulating factor (G-CSF) dependent patients after its discontinuation.[Ref]

Hepatic

-Serious veno-occlusive liver disease occurred in 7% of patients.[Ref]

Very common (10% or more): Increased alanine aminotransferase (24%), hyperbilirubinemia (10%)

Common (1% to 10%): Veno-occlusive liver disease[Ref]

Local

Very common (10% or more): Procedural pain (15%)

Metabolic

Very common (10% or more): Decreased appetite (24%), hyponatremia (10%), hypophosphatemia (20%), hyperglycemia (14%), hypokalemia (12%)[Ref]

Musculoskeletal

Very common (10% or more): Musculoskeletal pain (37%)[Ref]

-Musculoskeletal pain includes musculoskeletal pain, musculoskeletal chest pain, bone pain, musculoskeletal discomfort, chest pain, myalgia, neck pain, non-cardiac chest pain, pain in extremity, spinal pain, tendon pain, and back pain.[Ref]

Nervous system

Very common (10% or more): Headache (29%)[Ref]

-Headache includes headache and migraine.[Ref]

Other

Very common (10% or more): Pyrexia (49%), fatigue (12%), viral infection (17%)

Common (1% to 10%): Sepsis

Frequency not reported: Platelet engraftment delay[Ref]

-Viral infection includes BK virus infection, positive human rhinovirus, influenza, influenza like illness, parainfluenza virus infection, rhinovirus infection, and positive SARS-CoV-2.

-Sepsis includes sepsis, bacterial sepsis, neutropenic sepsis, and fungal sepsis.[Ref]

Respiratory

Very common (10% or more): Upper respiratory tract infections (15%), nasopharyngitis (12%), epistaxis (42%), cough (34%), oropharyngeal pain (15%), dyspnea (12), hypoxia (12%), rhinitis (12%)

Common (1% to 10%): Pneumonia[Ref]

-Upper respiratory tract infections include upper airway cough syndrome, upper respiratory tract infection, viral upper respiratory tract infection, pharyngitis, and pharyngitis streptococcal.

-Cough includes cough, upper-airway cough syndrome, and productive cough.

-Oropharyngeal pain includes oropharyngeal pain, oral pain, oropharyngeal discomfort, and jaw pain.

-Rhinitis includes rhinitis, rhinorrhea, and allergic rhinitis.[Ref]

References

1. Product Information. Zynteglo (betibeglogene autotemcel). bluebird bio. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.